THXID? BRAF 410697

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2016-12-28 for THXID? BRAF 410697 manufactured by Biomerieux Sa.

Event Text Entries

[63621005] A customer in united states notified biom? Rieux of a product problem when using the thxid braf product. The customer reported after dilution of the positive control with 150 l as specified in the protocol, the nano drop quantity is around 2 ng/ l and the assay failed with an invalid positive control. The customer reported diluting the positive control with less volume (50 l), the nano drop reading is around 7 ng/ l. The assay did function correctly with a higher concentrated positive control. Due to the repeat testing before using another assay, the customer indicated a delay in reporting results. There is no indication or report from the customer that the product problem led to any adverse event related to the patient's state of health. An internal biom? Rieux investigation has been initiated.
Patient Sequence No: 1, Text Type: D, B5


[69042374] Biom? Rieux conducted an internal investigation: several tests were performed internally in order to check the performance of the product. A total of (b)(4) pc were tested and the results were within the expected specifications. Also, customer returned samples were analyzed and during the investigation it was noted that there was no fluorescence for both runs and for both targets (v600e and v600k) which is rare for the internal control. The discrepancy observed by the customer is likely due to handling or equipment used by the customer. It is recommended that the customer consult with the biom? Rieux local representative regarding handling steps described in the instruction for use, especially: - after addition of 150? L of positive control diluent to the positive control sphere, mix at full speed using a vortex-type mixer until a clear solution has been obtained. - after addition of the 2? L of positive control: several aspiration/dispensing with the pipette are necessary to allow a good homogenization of the pc in the mix. We advise to count a minimum of 5 aspiration/dispensing. Since the root cause of the discrepancy is related to use error no corrective action is warranted at this time.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3002769706-2016-00533
MDR Report Key6211049
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2016-12-28
Date of Report2017-02-21
Date Mfgr Received2017-01-24
Date Added to Maude2016-12-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactELLEN WELTMER
Manufacturer Street595 ANGLUM ROAD
Manufacturer CityST. LOUIS MO 63042
Manufacturer CountryUS
Manufacturer Postal63042
Manufacturer G1BIOMERIEUX, INC
Manufacturer Street595 ANGLUM ROAD
Manufacturer CityST. LOUIS MO 63042
Manufacturer CountryUS
Manufacturer Postal Code63042
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameTHXID? BRAF
Generic NameTHXID? BRAF
Product CodeOWD
Date Received2016-12-28
Catalog Number410697
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIOMERIEUX SA
Manufacturer AddressCHEMIN DE L ORME MARCY L ETOILE, RHONE 69280 FR 69280


Patients

Patient NumberTreatmentOutcomeDate
10 2016-12-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.